Comments
Indian board rejects AstraZeneca's patent plea on cancer drug
28.11.2012. | (Reuters) - India's patents appeal board has dismissed British drugmaker AstraZeneca's petition challenging an earlier ruling that refused patent protection for a cancer-fighting drug, in the latest blow for Big Pharma in the country....
